Clinical trial
Investigation of Novel and Established Therapies in a Human Intravenous Lipopolysaccharide Model of Sepsis
NCT06626984 is registered in ClinicalTrials.gov with Belfast Health and Social Care Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation of Novel and Established Therapies in a Human Intravenous Lipopolysaccharide Model of Sepsis
- Lead sponsor
- Belfast Health and Social Care Trust
- Phase
- Phase 1/2
- Overall status
- Not yet recruiting
- Start date
- December 1, 2024
- Completion date
- July 1, 2026
- Enrollment
- 65 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
endothelial dysfunction, fluid overload, microcirculation, sepsis